Back to search
FDAFDA · Food and drugs·Recall number D-0655-2022

0.9% Sodium Chloride Injection USP, 250 mL Excel Container, Rx only, B. Braun Medical Inc., Bethlehem, PA, NDC 0264-7800-20

Published March 23, 2022 · Recall initiated: February 25, 2022

Summary

FDA records drug Class II recall D-0655-2022, published March 23, 2022 and initiated February 25, 2022. Recalling firm: B. Braun Medical, Inc.; Status: Terminated; Reported quantity: 33,742 bags; Lot: Lot #: J1E086, J1E204, J1E213, Exp 5/31/2023; J1H137, J1H138, Exp 6/30/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of sterility assurance: leaking bags

What to do

Voluntary: Firm initiated · Other

Get an email if SODIUM CHLORIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
SODIUM CHLORIDE
Manufacturer
B. Braun Medical, Inc.
Distributor
USA Nationwide
Lot
Lot #: J1E086, J1E204, J1E213, Exp 5/31/2023; J1H137, J1H138, Exp 6/30/2023
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was 0.9% Sodium Chloride Injection USP, 250 mL Excel Container, Rx only, B. Braun Medical Inc., Bethlehem, PA, NDC 0264-7800-20 recalled?

Yes. FDA published recall D-0655-2022 on March 23, 2022. Reported hazard: Lack of sterility assurance: leaking bags

What should I do if I have this product?

Voluntary: Firm initiated · Other

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: SODIUM CHLORIDE.